New LONG COVID survey by YouGov (commissioned by @LongCovidSOS):
🚨Over 4% of respondents have Long Covid
🚨A further 6% said they might have LC but weren’t sure
🚨1 in 3 reported knowing someone with Long Covid
🚨25% were concerned about Long Covid
Risk if Long Covid with reinfection:
In this study : ▶️ The risk was 33% for those infected for the first time ▶️ But the risk was 43% among those who experienced reinfection
“Matt McGorry opened up about how contracting long COVID has altered his life.
On October 29th, the How to Get Away with Murder actor shared an eight minute long video on Instagram where he spoke about his struggles with the symptoms of the virus. “
Risk of long COVID reaches 37% after three infections, according to INSPQ The risk of developing long COVID increases with each COVID-19 infection.
It is estimated at 13% after one infection, 23% after two infections, and 37% after three infections.
Western researchers closing in on treatment for long COVID…The CEO of Google founded the Schmidt Institute for LongCovid.
“SILC-supported researchers are studying the symptoms of 6,000 patients & looking for clues in their blood—particularly the behavior of thousands of proteins & hundreds of biological markers—to determine the pathology of LongCovid & why & how it persists…
In the future, SILC & its research partners .. aim to use this information to find therapeutics & improved tests for LongCovid.”
“#LongCovid can lead to organ damage, inflammation, and blood abnormalities.
Clinically Vulnerable people are already dealing with health challenges. Health privilege can mean that those unaffected may not fully grasp that, for us, additional damage is not an acceptable risk.”
Harvard Medical School study published in the International Journal of Infectious Diseases estimated that the following percentages of people have long Covid:
31% of moderately or severely infected individuals in North America
44% in Europe
51% in Asia
“No one talks about Covid anymore...
…but meanwhile, MILLIONS of people are suffering, many bedridden behind closed doors.
The GP-Patient Survey recently revealed that 4.6% of the population have Long Covid.”
“Evusheld tx my long COVID
Evusheld is a combo of 2 long-acting monoclonal antibodies Tixagevimab/cilgavimab
in 2021 I got this tx for acute COVID infection ⬇️ Prevented me from becoming hospitalized, I felt better within 45 mins of injection & my long COVID from 2020 resolved” Thread:
“Long Covid can affect nearly every organ system resulting in various symptoms including fatigue, cognitive dysfunction, post-exertional malaise, autonomic dysfunction, and chronic conditions including new onset diabetes, cardiovascular disease, gastrointestinal and neurologic disorders.2 Long Covid can affect people across the lifespan and across age, race and ethnicity, and baseline health status.3 Chinese scientists were among the first to report Long Covid in people who survived the acute phase of Covid-19.4 However, these early seminal Chinese studies on Long Covid were exclusively from Wuhan – where the pandemic originated. Because of China’s zero Covid policies, infection rates plummeted quickly in Wuhan and were very low and sporadic outside of Wuhan for much of 2020, 2021, and 2022. However, China relaxed its zero Covid policies at the end of 2022 which led to explosion of cases – hundreds of millions of Chinese got infected…”
“If 20% of those infected get Long COVID, and 37% of those quit work due to the symptoms, that’s over 7% of the people catching COVID that leave the workforce and school. (See Stanford study linked below)
That is a staggering number.
Let’s sanity check that. Figure some 60% of the population has been infected in the last year. So out of the workforce of 150m that would mean some 90m were infected and over 6m would have left the workforce from debilitating Long COVID just in the last year.
While that is a depressingly large number, it does match up with earlier surveys that estimated between 18-22m had left the workforce due to Long COVIS and never returned since the start of the pandemic almost five years ago.
So yes, those are huge numbers which comprise a huge drag on the US economy. It would be WAY cheaper to develop and deploy new vaccines and air quality improvements, even on a national scale. (And it would save a lot of lives and livelihoods as well.)
But worst thing about our current lackadaisical approach to public health, is that the damage is ongoing and will continue until we force our leaders to do something about it.”
“L0NG C0VID is not a simple yes or no; it exists on a spectrum that ranges from asymptomatic today to severe, with many nuances in between(Personal simplified perspective):
Asymptomatic: You may feel fine now, but future health issues could emerge in months or years to come.
Mild: You can carry out your daily tasks but face challenges that you might try to conceal from others.
Moderate: Your ability to perform everyday activities, such as work, sports, and hobbies, is noticeably affected, requiring adjustments to your routine.
Severe: You are bedridden and unable to function normally.
🔥Each new reinfection can increase the risk of developing Long COVID, potentially worsening the condition for those already suffering. And remember, LC has NO TREATMENT, NO CURE today, only some possible symptomatic relief at best.”
Norway study followed people for 22 months starting in March 2020 prior to infection. Memory and concentration problems persisted after infection, and didn't attenuate with time.
“Memory or concentration problems and dyspnoea were long-COVID symptoms.
•
Other long-COVID symptoms were anosmia, dysgeusia and fatigue…
…This can have profound effects on everyday functioning. The fact that cognitive symptoms are persistent, and most of the population have been, or will be, infected by the SARS-CoV-2 virus, makes it crucial that further research focuses on the pathophysiology, and treatment”
FDG-PET scans revealed persistent brain dysfunction in long covid
“Hypoconnectivity and absence of hypometabolism suggest that connectivity derangement in frontal networks could be related to protraction of neurological symptoms in long-term COVID patients.”
(MY NOTE: China vaccines are not MRNA technology. The better reduction in long-term Long Covid symptoms relative to multiple boosters compared to studies with MRNA patients is significant. Would like to see Long Covid data out of Cuba, a country that also did not use MRNA.)
Summary:
New study of 74,000 participants found:
-those infected with COVID had more other infections (including bacterial, influenza & mycoplasma infections)
-COVID reinfections had milder acute-phase symptoms but led to higher rate & severity of Long Covid
“Analysis of 68,200 valid responses revealed that the most frequent long COVID symptoms include fatigue (30.53%), memory decline (27.93%), decreased exercise ability (18.29%), and brain fog (16.87%). These symptoms were less prevalent among those infected only once: fatigue (24.85%), memory decline (18.11%), and decreased exercise ability (12.52%), etc. Women were more likely to experience long COVID, with symptoms varying by age group, except for sleep disorders and muscle/joint pain, which were more common in older individuals. Northern China exhibits a higher prevalence of long COVID, potentially linked to temperature gradients. Risk factors included underlying diseases, alcohol consumption, smoking, and the severity of acute infection (OR > 1, FDR < 0.05). Reinfection was associated with milder symptoms but led to a higher incidence and severity of long COVID (OR > 1, FDR < 0.05). Vaccination, particularly multiple boosters, significantly reduced long-term symptoms by 30%–70% (OR < 1, FDR < 0.05). COVID-19 participants also self-reported more bacterial, influenza and mycoplasma infections, and 8%–10% of patients felt SARS-CoV-2-induced chronic diseases.”
“Participants were randomly assigned via 2 × 3 parallel factorial randomisation (1:1:1:1:1:1) to receive metformin plus ivermectin, metformin plus fluvoxamine, metformin plus placebo, ivermectin plus placebo, fluvoxamine plus placebo, or placebo plus placebo.
When metformin was started within 3 days of symptom onset, the HR was 0·37 (95% CI 0·15–0·95). There was no effect on cumulative incidence of long COVID with ivermectin (HR 0·99, 95% CI 0·59–1·64) or fluvoxamine (1·36, 0·78–2·34) compared with placebo.
There was no effect on cumulative incidence of long COVID with ivermectin (HR 0·99, 95% CI 0·59–1·64) or fluvoxamine (1·36, 0·78–2·34) compared with placebo.
…Outpatient treatment with metformin reduced long COVID incidence by about 41%, with an absolute reduction of 4·1%, compared with placebo. Metformin has clinical benefits when used as outpatient treatment for COVID-19 and is globally available, low-cost, and safe.”
King’s College of London: “Long COVID symptoms prevalent among healthcare workers”
New research has found that 33.6% of surveyed healthcare workers in England report symptoms consistent with post-COVID syndrome
